JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

A3632 Motesanib

Target: VEGFR

Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit

≥42 mg/mL
A8219 Gefitinib (ZD1839)

3 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
A3573 LY2801653

Target: MET

Summary: MET inhibitor

≥27.65 mg/mL
A3558 LRRK2-IN-1

1 Citation

Target: LRRK2|DCLK2

Summary: LRRK2 inhibitor,cell-permeable and ATP competitive

≥28.55 mg/mL
A2133 Saracatinib (AZD0530)

3 Citation

Target: Src

Summary: Src/Abl inhibitor,potent and selective

≥27.1 mg/mL
A2168 Dovitinib (TKI-258, CHIR-258)

2 Citation

Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR

Summary: Multitargeted RTK inhibitor

insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL
B2297 GW441756

1 Citation

Target: Trk Receptors

Summary: TrkA inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
A8546 R406

1 Citation

Target: Syk

Summary: SYK inhibitor,potent and ATP-competitive

≥31.45 mg/mL
A3818 Silvestrol

Summary: Antineoplastic

Soluble in DMSO